In an era where healthcare is rapidly transforming, diagnostics has emerged as far more than a supporting function it has become the foundation of modern medicine. This central theme unfolded in a recent episode of the InnoHealth Magazine Podcast, where host Dr. Soumya Singh engaged in a deep, nuanced conversation with Dr. Shelly Mahajan, Lab Director & Clinical Head – Genomics at Mahajan Imaging & Labs.

The discussion moved beyond innovation buzzwords to examine the real-world impact of genomics, artificial intelligence, standardization, ethics, and most importantly patient trust.

Diagnostics Moves From the Background to the Frontline

For decades, diagnostics functioned quietly in the background of healthcare. Patients rarely interacted with diagnosticians, and lab reports were often viewed as secondary confirmations of a clinician’s judgment. According to Dr. Mahajan, that perception has fundamentally changed.

“Diagnostics is no longer about confirming illness. It is about predicting disease, preventing it, and managing a person’s entire health journey.”

This shift reflects a broader transformation in healthcare itself. Preventive screenings, wellness monitoring, and early risk assessment now rely heavily on diagnostics. Individuals today engage with testing not only when they are sick, but also when they want to stay healthy making diagnostics a part of everyday life rather than episodic care.

Molecular Diagnostics and the Democratization of Precision

One of the most powerful drivers of this change has been molecular diagnostics. What was once considered niche or highly specialized is now increasingly accessible to routine patients. Dr. Mahajan highlighted how PCR and genomic testing have become household terms, especially following the COVID-19 pandemic.

“Today, we can predict susceptibility to disease by testing DNA from a simple blood or saliva sample and that has completely changed how early we can intervene.”

Molecular diagnostics has revolutionized disease detection across oncology, infectious diseases, and autoimmune disorders. The ability to diagnose earlier, predict risk, and tailor treatment plans has pushed healthcare closer to the ideal of personalized medicine—where therapy is shaped around the individual rather than the average patient.

Artificial Intelligence: Acceleration With Accountability

Artificial intelligence has emerged as a powerful force within diagnostics, improving efficiency, speed, and accuracy in radiology and pathology. AI-powered tools can now screen pathology slides, assist radiologists in detecting early cancers, and reduce diagnostic delays—particularly in regions with limited access to specialists.

However, Dr. Mahajan was unequivocal in her caution: AI is a tool, not a decision-maker.

“AI can screen faster and reduce errors, but it cannot replace clinical judgment. Without human oversight, even the smartest algorithm can misdiagnose.”

She emphasized that AI systems are only as good as the data on which they are trained. A lack of diversity or quality in training datasets can introduce bias, leading to skewed results that directly impact patient care. Continuous validation, transparency, and regulatory oversight are therefore critical to safe AI adoption.

Standardization: The Backbone of Credibility

One of the most pressing concerns raised in the conversation was the lack of uniformity across diagnostic laboratories. Variations in reference ranges, methodologies, and reporting standards often leave patients confused and clinicians uncertain.

Dr. Mahajan stressed that accreditation, adherence to international quality standards, regular audits, calibrated equipment, and continuous staff training are not optional—they are fundamental. Without standardization, diagnostics risks becoming volume-driven rather than value-driven, leading to over-testing, patient anxiety, and unnecessary healthcare costs.

Over-Testing and the Need for Value-Based Diagnostics

While access to diagnostics has improved, it has also created a paradox: more testing does not always mean better care. Over-testing can result in false positives, misdiagnosis, and emotional distress for patients.

Dr. Mahajan advocated for stronger collaboration between clinicians and diagnosticians, evidence-based testing protocols, and better patient education. The goal, she explained, is smarter diagnostics, not more diagnostics.

“We need to move away from volume-based diagnosis and focus on tests that actually add value to a patient’s treatment journey.”

Transparency, Ethics, and Rebuilding Patient Trust

Addressing recent controversies around lab practices and data integrity, Dr. Mahajan underscored that trust is fragile—and once lost, difficult to rebuild. Transparency, she argued, is the most powerful tool laboratories have.

She noted a positive cultural shift: patients now actively want to speak with diagnosticians, discuss reports, and understand their health data. This growing engagement reflects a new era where patients expect not just accuracy, but accountability and empathy.

The Road Ahead: Technology With a Human Core

Looking forward, Dr. Mahajan expressed optimism about emerging breakthroughs such as multi-omics diagnostics, AI-assisted tools for rural healthcare, and continuous monitoring through wearables. These innovations promise earlier detection, ultra-personalized treatment, and improved access.

Yet the podcast made one truth abundantly clear: technology alone cannot define the future of diagnostics.

The future will belong to systems that combine scientific excellence, ethical practice, rigorous quality standards, and human judgment—where every report carries not just data, but responsibility.

As this episode of the InnoHealth Magazine Podcast demonstrates, diagnostics is no longer just about tests. It is about trust, transparency, and putting patients at the heart of innovation. 

The post Diagnostics at the Frontline of Modern Healthcare: From Disease Detection to Prevention appeared first on InnoHEALTH magazine.

Remember when getting vaccinated against COVID-19 became a key part of life? That’s where mRNA vaccines like Pfizer and Moderna came in, changing the game in public health. Understanding how these vaccines work is crucial, especially with all the buzz and misinformation out there. 

By learning about mRNA vaccines, you’re not just grasping a piece of medical technology, but also empowering yourself to make informed health choices. In this article, we’ll break down how mRNA works, how these vaccines differ from traditional ones, their safety, and what the future holds for this innovative technology.

What is mRNA?

mRNA stands for “messenger ribonucleic acid”—basically, it’s a tiny instruction manual your body uses to make proteins. Every cell in your body has mRNA, and it’s natural. Think of it like a recipe card copied from your DNA and handed to your body’s protein-making kitchen. It tells your cells which proteins to build to keep you alive and healthy. Scientists have known about mRNA for decades. 

What is new is how we’re now using it in medicine, especially vaccines. Instead of injecting part of a virus, mRNA vaccines give your body the code to make a small, harmless piece of it. Your immune system then sees that piece, realizes it doesn’t belong, and prepares to fight. 

How Do mRNA Vaccines Work?

Here’s the simple version: mRNA vaccines deliver a tiny piece of lab-made mRNA into your body. This mRNA carries the blueprint for a harmless part of a virus, like the spike protein from COVID-19. Once your cells read the instructions, they make that spike protein and show it to your immune system. 

Your immune system then says, “Hey, that doesn’t belong here,” and gets to work building defenses. So if the real virus shows up later, your body is ready to fight it off fast.

Important note: mRNA never enters the nucleus of your cells and can’t change your DNA. It breaks down naturally after its job is done. 

Scientists can design mRNA vaccines quickly. The technology is fast, flexible, and precise—like sending your immune system a high-speed training manual.

How Are mRNA Vaccines Different from Traditional Vaccines?

Here’s how mRNA vaccines stack up against traditional types:

Key Differences with mRNA Vaccines:

• Speed: Traditional vaccines often take years to develop, requiring growing viruses or purifying proteins. mRNA vaccines can be developed and modified quickly in response to new viral variants.
• Flexibility: They can be adapted for different viruses without cultivating live pathogens.
• Scalability: Production is efficient, allowing for rapid scaling to meet public health needs.

These characteristics make mRNA vaccines a powerful tool in modern medicine.

Are They Safe? Common Misconceptions Explained 

Safety is always the biggest concern. mRNA vaccines underwent rigorous clinical trials involving tens of thousands of people. The result? They’re incredibly safe.  

Another concern is side effects. Some people feel sore or tired, and they may get a fever. That’s a positive sign that the immune system responds and builds protection.

Real-world data continues to back this up. Healthcare professionals, many in online BSN to DNP programs, now learn about mRNA tech as part of modern medical training. Bottom line: the benefits massively outweigh the risks. 

The Future of mRNA Technology 

The potential of mRNA technology goes beyond just COVID-19 vaccines. Scientists are excited about its applications in developing cancer vaccines targeting specific tumours and triggering the immune system to attack cancer cells. mRNA technology is also being explored for vaccines against other infectious diseases like influenza, Zika virus, and respiratory syncytial virus (RSV). 

Personalized medicine is another promising area; researchers are looking at tailoring mRNA vaccines to fit individual patient profiles, which could revolutionize how we approach treatments. The rapid advancements in mRNA technology showcase its effectiveness in fighting current viruses and open up new possibilities for preventing diseases we once considered challenging to tackle.

mRNA vaccines represent a giant leap forward in how we fight disease. They’re safe, effective, and a prime example of how science can adapt to meet urgent global needs. Understanding how they work helps us reduce the noise and make informed health choices. Encouraging informed discussions and trust in science. Whether you’re curious or cautious, keep asking questions. The more we learn, the better prepared we are for whatever comes next.

The post Understanding mRNA Vaccines: How Do They Work? appeared first on InnoHEALTH magazine.

Session- 1: Inaugural Session

The 7th edition of the InnoHEALTH Conference at IIIT Delhi brought together a diverse group of healthcare professionals, innovators, and visionaries. This year’s event was marked by powerful speeches, groundbreaking ideas, and heartfelt tributes to the late Surgeon Rear Admiral Dr. V.K. Singh, a pioneer in healthcare innovation.

The session began with a warm welcome from the master of ceremony, Ms. Tuba khan and Ms. Mariam Khan, who emphasized that innovation is the driving force behind improving healthcare outcomes. They introduced InnoHEALTH, a premier platform created by InnovatioCuris in partnership with IIIT Delhi, that fosters collaboration among global thought leaders and practitioners.

Key Highlights from the Esteemed Speakers

Dr. Tavpritesh Sethi

As the host representative from IIIT Delhi, Dr. Tavpritesh Sethi welcomed attendees, emphasizing the institute’s commitment to harnessing AI and digital technologies to transform healthcare and address global challenges like climate change. He reflected on Dr. Singh’s role in shaping the conference and commended the growing engagement of innovators in tackling real-world problems.

Major General Dr.Jagtar Singh

In a moving tribute to the late Dr. V.K. Singh, Major General Dr. Jagtar Singh recounted his unparalleled contributions to the Armed Forces Medical Services and civilian healthcare systems. He shared anecdotes about Dr. Singh’s visionary leadership, including his pioneering efforts in combat medical care, ambulance systems, and field hospital innovations. His speech was a heartfelt reminder of Dr. Singh’s humility, dedication, and unwavering commitment to innovation.

Dr. Shirshendu Mukherjee

Dr. Shirshendu Mukherjee, MD of Wadhwani Innovation Network, spoke about his collaborative journey with Dr. V.K. Singh, starting in 2010. He highlighted Dr. Singh’s foresight in nurturing India’s innovation ecosystem and recalled their joint initiatives, including grant-writing workshops for young innovators. Dr. Mukherjee described Dr. Singh as an exceptional mentor who valued teamwork and consistently empowered those around him to excel.

(Hony.) Brig.Dr. Arvind Lal

Honorary Brigadier Dr. Arvind Lal, Chairman of Dr. Lal Path Labs, reflected on the role of innovation in healthcare transformation. He lauded Dr. Singh’s leadership in managing crises and establishing healthcare systems during emergencies. Dr. Lal also emphasized the importance of regulation, collaboration, and investment in fostering a robust healthcare innovation ecosystem, projecting a bright future for India as a global leader in healthcare solutions.

Sachin Gaur

Director of Operations at InnovatioCuris, Sachin Gaur, expressed his gratitude to the speakers and attendees. He shared personal reflections on working with Dr. Singh, describing him as a mentor who championed innovation and inspired people from all walks of life. Sachin highlighted the importance of creating platforms for young innovators and urged participants to carry forward Dr. Singh’s legacy by fostering inclusive and impactful innovations.

Legacy of Dr. V.K. Singh

Throughout the conference, speakers reiterated Dr. Singh’s contributions, from his groundbreaking studies in ambulance systems to his global impact on healthcare management and innovation. His legacy, embodied in the InnoHEALTH platform, continues to inspire the next generation of healthcare leaders.

The InnoHEALTH Conference 2024 served as a testament to the transformative power of innovation and collaboration. The insights and experiences shared by the speakers not only honored Dr. Singh’s memory but also charted a course for a future where healthcare innovation thrives in making a global impact.

https://youtu.be/PFw9C7wQCDs

Session- 2: Navigating the AI Frontier

(Transforming Healthcare with Large Language Models)

The InnoHEALTH Conference 2024 witnessed a groundbreaking session titled “Navigating the AI Frontier: Transforming healthcare with Large Language Models,” bringing together experts from various domains to explore the transformative potential of artificial intelligence (AI) in modern healthcare. Held at IIIT Delhi, the session delved into the opportunities, challenges, and future of Large Language Models (LLMs) in medical applications.

Setting the Stage for Innovation

The session began with an engaging introduction by the moderator, Mr. Sachin Gaur, Director of Operations at InnovatioCuris, who emphasized the paradigm shift AI is bringing to healthcare. He highlighted how LLMs have transitioned from futuristic concepts to indispensable tools, streamlining workflows and offering personalized healthcare solutions.

Interactive Demo: AI in Action

The session featured a live demo showcasing the capabilities of AI-powered virtual assistants. Attendees witnessed an AI medical assistant named “John” conducting a simulated patient interaction. The AI assistant demonstrated its ability to gather symptom details, generate structured reports, and provide preliminary assessments—all in real time.

This interactive demonstration underscored the practicality of AI in enhancing efficiency and accuracy in patient care. The audience was impressed by how such tools could transform mundane tasks, allowing healthcare professionals to focus on critical decision-making.

Expert Insights and Discussions

1. Mr. Ganesh Gopalan, Co-founder and CEO of Gyani AI:
   With over 25 years of experience in technology and marketing, Mr. Gopalan showcased the practical applications of AI in healthcare. He highlighted how LLMs enhance patient care through real-time insights and scalable solutions, revolutionizing traditional medical practices.
2. Dr. Tavpratesh Sethi, Associate Professor of Computational Biology, IIIT Delhi:
   Dr. Sethi explored the use of LLMs in analyzing complex medical data, such as ICU monitoring and patient trajectory predictions. He stressed the need for interoperability and standardized frameworks to optimize AI’s integration into healthcare systems.
3. Kshitij Jadhav, Assistant Professor at Koita Center for Digital Health, IIT Bombay:
   Dr. Jada focused on how AI-powered tools can improve community health by providing scalable, customized solutions. He highlighted case studies where LLMs have been deployed successfully in resource-constrained settings to deliver timely medical advice.
4. Dr. Suvrankar Datta, Senior Resident, AIIMS Delhi:
   Dr. Datta shared his journey transitioning from clinical practice to AI research. He emphasized the potential of open-source AI tools in democratizing healthcare technology and enabling cost-effective solutions for Indian medical setups.
5. Dr. Amit Raj, Medical Director, Plexus Medcare:
   As a cardiologist with over a decade of experience, Dr. Raj underscored the importance of AI in generating precise and actionable medical reports. He advocated for the use of LLMs in simplifying complex medical terminologies for better patient comprehension.
6. Dr. Vijay Agrawal, President, Consortium of Accredited Healthcare Organizations (CAHO):
   Dr. Agrawal addressed the critical need for problem-centric AI solutions in healthcare. He proposed creating a directory of validated healthcare apps and tools to foster trust and ensure large-scale adoption of AI technologies.

A Glimpse Into the Future

The panelists collectively envisioned the evolution of AI in healthcare, identifying promising areas such as:

• Real-time patient monitoring: Continuous vital sign tracking to predict and prevent emergencies.
• Interoperable frameworks: Developing standardized systems to enhance data sharing and AI training.
• Open-source collaboration: Leveraging open-access tools to bridge resource gaps in global healthcare.
• Customizable AI models: Tailoring LLMs to specific clinical settings for optimized performance.

Celebrating Contributions

The session concluded with felicitation ceremonies for the speakers, acknowledging their invaluable contributions to the conference. Attendees left inspired, with actionable insights to leverage AI in reshaping healthcare delivery.

The InnoHEALTH Conference 2024 exemplified how technology and innovation can converge to address complex healthcare challenges. By fostering dialogue among industry leaders, the event underscored the immense potential of AI to transform healthcare into a more accessible, efficient, and patient-centric system.

https://youtu.be/KRPMtqyJO2s?si=fcLtLhGfYBL43acR

Session- 3: The shift in healthcare AI

(From CNNs to Foundation Models, Vision-Language Models, and LLMs)

The InnoHEALTH 2024 conference, Session 3, titled “A Shift in Healthcare AI: From CNNs to Foundation Models, Vision-Language Models, and LLMs“, brought together a panel of experts who delved into how these technologies are reshaping diagnostics, predictive analytics, and patient care.

Highlights from the Panelists

Dr. Vasanth Venugopal (Moderator)

Dr. Vasanth opened the session by highlighting AI’s rapid evolution from a concept to a practical tool in healthcare. He emphasized the role of large language models (LLMs) and vision-based AI in improving diagnostic accuracy and efficiency. He underscored the need for interdisciplinary collaboration to integrate these tools effectively into healthcare systems.

Dr. Devasenathipathy Kandasamy

Dr. Kandasamy discussed the transformative impact of AI in clinical research. He explained how machine learning algorithms streamline clinical trials by automating data analysis and patient recruitment. This has significantly reduced time and costs associated with research. He also stressed the ethical considerations of using AI in clinical settings, advocating for transparency and robust data governance.

Dr. Tarun Kaushik

Drawing from his experience in nephrology, Dr. Kaushik focused on AI’s application in managing kidney diseases. He highlighted AI-powered dialysis machines that monitor patient vitals and blood parameters in real time. These systems can optimize treatment plans and predict complications, improving patient outcomes. Dr. He also addressed the cost challenges of implementing AI technologies in resource-constrained environments but expressed optimism about their future accessibility.

Dr. Mrittunjoy Guha Majumdar

Dr. Majumdar introduced the concept of Quantum Machine Learning (QML), a cutting-edge approach combining quantum computing and AI. He explained how QML leverages quantum properties like superposition and entanglement to process complex datasets more efficiently. Dr. Majumdar illustrated its potential in genomics, drug discovery, and personalized medicine, while acknowledging the challenges of high computational costs and limited quantum infrastructure in India. He predicted that QML’s widespread adoption is 3-5 years away, with research advancing rapidly.

Dr. Arti Pawaria

Dr. Pawaria brought insights into AI’s impact on pediatric and transplantation care. She shared how AI is being used in donor-recipient matching, optimizing surgical planning, and post-operative monitoring for pediatric liver transplants. AI also plays a critical role in managing rare and complex pediatric conditions, where conventional data is often inadequate. She emphasized the need for ethical safeguards to ensure responsible use of AI, particularly for vulnerable populations like children.

AI’s Expanding Role in Healthcare

The panel collectively highlighted AI’s ability to revolutionize healthcare by improving diagnostic precision, enhancing patient care, and enabling predictive analytics. Examples included:

• AI-assisted radiology for early detection of cancers and other diseases.
• Predictive models to monitor chronic conditions, such as kidney and liver diseases.
• Personalized medicine solutions for pediatric care and complex surgeries.

Challenges and Ethical Considerations

The panelists acknowledged that while AI and QML hold immense promise, they also bring challenges:

• Data Privacy: Safeguarding patient information is crucial as AI systems process sensitive data.
• Cost of Technology: High implementation costs limit accessibility, particularly in developing countries.
• Regulatory Frameworks: Evolving legal and ethical standards are necessary to govern the use of these emerging technologies.

The panel stressed the importance of creating robust frameworks to ensure that AI and QML are used responsibly and equitably.

The Future of AI and QML in Healthcare

The session concluded with a forward-looking vision of AI and QML as tools that augment human expertise rather than replace it. Collaboration between healthcare professionals, technologists, and policymakers will be essential to unlocking the full potential of these technologies.

InnoHEALTH 2024 reaffirmed its role as a platform for innovation and collaboration, showcasing how advanced technologies can lead to more efficient, equitable, and innovative healthcare systems.

https://youtu.be/vkvKC4WiZAE

Composed by:

InnoHEALTH Magazine Digital Team

The post Advancing healthcare through Innovation & Sustainability appeared first on InnoHEALTH magazine.

In a rapidly evolving healthcare landscape, technology, innovation, and expertise converge to shape the future. Dr. Bhupendra Rana, a distinguished figure in healthcare Accreditation , recently shared his valuable insights on the InnoHEALTH Podcast. His perspectives shed light on the transformative power of digital health, the challenges of modern medicine, and the promising future of healthcare.

A Vision for the Future of Healthcare

Dr. Rana began the conversation by emphasizing the urgent need for healthcare systems to adapt to the rapidly changing world. With the rise of digital health technologies, such as telemedicine, AI-driven diagnostics, and wearable devices, the potential for more personalized and efficient patient care has never been greater. He pointed out that these advancements not only improve access to healthcare but also ensure that patients receive timely interventions, particularly in underserved regions.

Challenges in Digital Health Implementation

Despite the promise of digital health, Dr. Rana acknowledged the significant challenges that come with it. One of the primary hurdles is ensuring that these technologies are accessible and affordable to all, especially in developing countries like India. He stressed that while urban areas may benefit from advanced healthcare tools, rural regions often lag due to limited infrastructure and resources.

Dr. Rana also highlighted the need for regulatory frameworks that can keep pace with technological advancements. Ensuring patient data privacy and security in a digital-first healthcare ecosystem is critical, and he called for robust policies to protect sensitive information.

The Role of AI in Healthcare

Artificial intelligence (AI) featured prominently in the discussion. Dr. Rana elaborated on how AI is revolutionizing diagnostics, treatment planning, and even drug development. From AI algorithms that analyze medical images to predict diseases early, to systems that assist doctors in making more informed decisions, the technology is reshaping the healthcare landscape.

However, Dr. Rana was quick to point out that AI should complement, not replace, human expertise. He emphasized the importance of a balanced approach where AI serves as a tool to enhance the capabilities of healthcare professionals rather than overshadow their critical judgment.

Bridging the Urban-Rural Divide

A significant portion of the conversation revolved around the disparity in healthcare access between urban and rural areas. Dr. Rana expressed concern over the urban-rural healthcare gap, noting that while cities are advancing with state-of-the-art facilities, rural areas still struggle with basic healthcare services. He advocated for more initiatives that bring healthcare technologies to rural communities, whether through mobile health units, telemedicine, or government-led programs.

Education and Training in the Digital Age

Education and training for healthcare professionals were also key points in Dr. Rana’s discussion. With the advent of new technologies, there is a pressing need for continuous learning and upskilling within the medical community. He suggested that healthcare institutions should focus on integrating digital health tools into their curricula and offer regular training sessions to ensure that professionals remain adept at using the latest innovations.

Looking Ahead: A Collaborative Effort

Towards the end of the podcast, Dr. Rana called for a collaborative approach to healthcare innovation. He believes that the future of healthcare lies in the collective efforts of governments, private sector players, and the medical community. By working together, these stakeholders can develop solutions that are not only innovative but also practical and scalable across different regions.

Authors Biography

Dr. Bhupendra Kumar Rana, is the founding CEO of QAI, former Director of NABH, and an expert in healthcare accreditation and quality. He has served on several global committees and authored numerous publications on patient safety and standards.

The post Revolutionizing Healthcare: Digital Innovation, AI, and Bridging Access Gaps appeared first on InnoHEALTH magazine.

Artificial intelligence (AI) is driving a monumental shift across industries, and healthcare is at the forefront of this transformation. Tanvi Lall, a Berkeley Haas MBA and strategic leader at People+ai, offers a unique perspective on how AI is poised to revolutionize healthcare delivery and what the future holds for this critical sector. Her insights provide a roadmap for navigating both the opportunities and challenges of integrating AI into healthcare.

Bridging the Gap Between AI Hype and Reality

After eight years leading the development and commercialization of molecular diagnostics for infectious diseases, with a background as an investor and strategist at Visby Medical, Lall has witnessed firsthand the limitations of traditional life sciences approaches, which often rely on time-consuming laboratory trials. She believes the healthcare industry is only beginning to tap into the full potential of software, data science, and particularly generative AI. With AI’s multilingual capabilities, Lal sees unprecedented possibilities to revolutionize healthcare delivery—especially in diverse, multi-lingual countries.

However, she is quick to note that practical AI deployment in healthcare remains complex. “You cannot develop a product or technology without truly understanding the nuances of the stakeholders’ needs,” says Lall. The complexity lies in healthcare’s unique structure, where the payer, operator, and beneficiary of a technology are often different entities. Success, she argues, depends on a deep understanding of all three perspectives.

Key Strategies for AI Integration in Healthcare

For healthcare organizations looking to leverage AI effectively, Lall highlights several key strategies:

1. Clear Communication: Healthcare is traditionally conservative, especially when it comes to adopting new technologies. Organizations need to craft clear, transparent narratives around their AI solutions, addressing concerns about privacy, security, and data handling.
2. User-Centric Development: The development process must involve direct engagement with end-users in their real-world environments. For example, AI solutions designed for physicians should be tested in clinics and offices to ensure they fit seamlessly into existing workflows.
3. Ethical Considerations: The handling of sensitive patient data is paramount. Organizations must prioritize data privacy and consent management while backing AI tools with clinical validation through rigorous trials.

Emerging Opportunities and Evolving Roles

AI is not just a tool for innovation; it’s reshaping roles and creating new opportunities within healthcare:

• Localized Training: AI can help create personalized training materials tailored to users’ native languages and cultural contexts, making AI adoption more accessible across diverse populations.
• Productivity Tools for Providers: AI tools can enhance healthcare providers’ efficiency, enabling them to spend more time on complex decision-making and patient care.
• Streamlining Administration: By automating routine administrative tasks, AI allows healthcare professionals to focus more on delivering quality care.

The Future of AI in Healthcare: Personalized Medicine and Drug Discovery

Lal identifies two game-changing trends in healthcare AI:

• Personalized Medicine: AI’s ability to create holistic patient profiles by combining diagnostic data with lifestyle indicators is revolutionizing personalized treatment plans. In a country like India, where cultural and dietary differences play significant roles in health outcomes, AI can be particularly impactful.
• Drug Discovery: AI’s computational power is accelerating the exploration of drug combinations and molecular interactions, paving the way for faster and more efficient drug development.

Transforming Patient-Provider Relationships with AI

AI is also reshaping how patients interact with healthcare providers:

• AI-Powered Consultations: AI-driven systems can conduct preliminary consultations by gathering medical history and symptoms, streamlining the diagnostic process.
• Post-Consultation Support: Patients can receive AI-assisted guidance for medication and treatment follow-ups, ensuring they adhere to their care plans effectively.
• Improved Screening: AI is enhancing traditional screening processes, allowing for more accurate and timely diagnoses.

Advice for Innovators: Building Diverse Teams

For those looking to innovate in healthcare AI, Lall stresses the importance of building diverse teams that go beyond just engineers. She advises innovators to include healthcare professionals and end-users in the development process from the beginning. “Curate a core team that brings varied perspectives, and gather early feedback from the community,” she suggests. This approach ensures that solutions are not only technologically advanced but also practical and effective in real-world settings.

AI’s role in healthcare is both transformative and complex. As the technology continues to evolve, success will depend on balancing cutting-edge innovation with ethical considerations and a deep focus on user needs. By embracing this approach, AI has the potential to significantly enhance healthcare accessibility, efficiency, and outcomes—ultimately leading to better care for patients worldwide.

Authors Biography

Tanvi Lall is the Director of Strategy at People+ai and former Director of Program Management at Visby Medical, with prior roles at Berkeley Impact Venture Partners and Biocon. She holds an M.Sc. in Biotechnology and Management from Carnegie Mellon and an MBA from UC Berkeley, advising on biotechnology careers.

The post AI and Healthcare: Revolutionizing Delivery, Efficiency, and Personalization appeared first on InnoHEALTH magazine.

In a recent conversation, Rohit Ghosh, a distinguished expert in healthcare AI and former executive at Cure.ai, shared his profound insights into the game-changing role of artificial intelligence in modern healthcare. His journey, from diverse fields like investment banking and logistics to the forefront of healthcare AI, highlights the powerful impact of innovative technology on improving medical practices and patient outcomes worldwide.

A Journey Towards Healthcare Transformation

Ghosh’s transition to healthcare AI was driven by a desire to make a lasting difference. After a brief stint in industries unrelated to healthcare, he recognized his passion for leveraging advanced technology to save lives. This realization led to the co-founding of Cure.ai, where Ghosh dedicated eight years to developing AI-driven solutions aimed at addressing some of the biggest challenges in healthcare.

The Integration of AI in Healthcare and Its Benefits

The integration of AI into healthcare systems has been particularly effective in the field of medical imaging. Ghosh explains that AI has three primary benefits in radiology:

1. Enhanced Efficiency: Traditionally, radiologists spend significant time analyzing medical images like CT scans and MRIs, which can take up to 30 minutes. With AI-powered pre-analysis, this time is drastically reduced, allowing radiologists to focus on the most critical areas.
2. Improved Accuracy: AI excels in detecting minute details that might be missed by the human eye. Whether it’s a tiny nodule in the lungs or a subtle brain bleed, AI improves the precision of diagnosis by complementing human expertise.
3. Early Detection: One of the most significant advantages of AI is its ability to catch incidental findings, such as detecting early-stage cancer in patients who are being scanned for unrelated issues. Early detection can lead to life-saving interventions.

Reducing Healthcare Inequities

One of the most profound impacts of AI, according to Ghosh, is its ability to reduce healthcare disparities, especially in underserved and rural areas. AI can democratize access to high-quality care by enabling timely diagnoses, even in remote locations:

• Rural Hospitals: In areas where radiologists aren’t available around the clock, AI can provide immediate diagnostic support for urgent conditions like strokes.
• Tuberculosis: AI-driven diagnostics can reduce the time needed for tuberculosis diagnosis from weeks to just one hour, a critical improvement in areas where the disease is prevalent.
• Remote Care: AI bridges the gap between rural and urban healthcare, ensuring that patients in remote locations receive the same standard of care available in major cities.

Overcoming Challenges

While the potential of AI in healthcare is immense, there are several challenges that must be addressed to fully realize its benefits:

• Awareness Gap: Many healthcare practitioners are still unaware of the full capabilities and limitations of AI in medical applications.
• Evaluation Expertise: Hospitals and healthcare providers need clear guidelines on how to evaluate and adopt AI solutions effectively.
• Policy and Regulation: Policymakers must keep pace with technological advancements, ensuring that regulations support innovation while safeguarding patient care.

Future Trends in AI and Healthcare

Looking ahead, Ghosh highlights several promising trends in healthcare AI:

• Personalized Medicine: AI is enabling the discovery of new biomarkers, leading to more targeted and individualized treatments.
• Preventive Healthcare: The shift from reactive care to proactive health monitoring will allow for earlier interventions and better health outcomes.
• Drug Discovery: AI is accelerating the development of new drugs, as well as optimizing combinations of existing medications for improved efficacy.

Building a Sustainable AI Ecosystem

For AI to truly revolutionize healthcare, collaboration among key stakeholders is essential. Policymakers, technologists, and healthcare professionals must work together to build a sustainable ecosystem that promotes innovation while ensuring that AI-powered healthcare solutions are accessible to all. Proper implementation, equitable access, and forward-thinking policies are the cornerstones of a future where AI plays a central role in patient care.

The journey of integrating AI into healthcare is a long but rewarding one. Persistence and collaboration will turn today’s innovations into tomorrow’s standard practices. AI’s potential to enhance healthcare is not just about technology, but about transforming the way care is delivered, especially in regions that need it most. By continuing to push the boundaries of AI, the healthcare industry can achieve a more equitable and efficient system, providing high-quality care for all.

Authors Biography

Rohit Ghosh, an IIT-Bombay graduate and Founding Member of Qure.ai, specializes in business development and strategy. A Google Developer Expert in Machine Learning, he has 15+ publications, including in The Lancet. Rohit mentors data science students, collaborates with GreyAtom, and speaks at global conferences on AI and ML.

The post Transforming Healthcare: The Game-Changing Role of AI in Equity and Innovation appeared first on InnoHEALTH magazine.

Identification of the entire genetic makeup of an organism has proven significance in genetic engineering. The technique has been widely used in research spaces and medical settings for numerous purposes. The genetic sequence is unique for each individual making it a critical aspect in analysing the whole genetic makeup more precisely, thus driving healthcare specialists more towards personalised treatment approaches for genetic or other chronic diseases. Whole genome sequencing technique has been widely used in research laboratories for devising novel strategic approaches in treatment of various fatal diseases.  The study and sequencing of genetic sequences has also aided in analysing disease specific genetic alterations that serves the purpose of identifying an individual’s susceptibility to a disease. Various genomic aberrations include inversion, amplification, translocation and deletion.

The technique delves into the molecular level of an organisms’ genetic makeup more specifically DNA. Several methods for sequencing have been studied till date, the Next gen sequencing being the most preferred one among the researchers. The NGS technique is used to determine the order in which the nucleotides are present in a specific genome or targeted regions of DNA or RNA. A typical workflow of NGS includes preparation of the library, followed by sequencing and finally data analysis. The massive parallel sequencing proves to be the remarkable part of the workflow allowing a massive number of DNA fragments to be sequenced simultaneously. This sequencing technology is widely known for its ultra-high throughput, speed and scalability. The technique gains an edge over other traditional sequencing techniques due to its increased efficiency in time and cost factors. 

Other sequencing techniques include Sanger Sequencing and Shot gun sequencing. Sanger sequencing is also known as the dideoxy chain termination method utilising the differentially labelled fluorescent dideoxy nucleotides as the chain terminators in the process. The Shotgun sequencing method utilises fragmentation to isolate multiple copies of chromosomal DNA of interest and eventually screen them using computed algorithms. The process is so-called based on the analogy with the rapidly expanding quasi-random firing pattern of the shotgun.  The key factor driving the process of Shotgun sequencing is that chromosomal fragments of the same chromosomal portions will have overlapping segments which can be easily sequenced and analysed. This emphasizes the process of redundant fragmentation and sequencing of the target DNA respectively. Computed algorithms then utilise the overlapping ends of the different reads to assemble them into a continuous sequence. This sequencing technology was one of the precursor technologies that were responsible for enabling full genome sequencing. Another uncommon sequencing approach known as Hierarchical or Top-down sequencing, wherein a low-resolution physical map of the genome is made prior to actual sequencing. Such a map paves way for sequencing a particular minimal number of fragments covering the entire chromosomes, thus minimizing the amount of high-throughput sequencing and assembly.

Dedicated sequencing-based historic studies, targeting healthcare, have earmarked the promising future that the whole genome sequencing technology holds. With a major breakthrough in cancer treatment by Ley et al. in 2008, the first whole genome sequence of an acute myeloid leukaemia sample was presented, thus demonstrating the possibility of identification of disease-associated mutations and druggable targets. This very year also marked the success of two studies based on non-invasive prenatal genetic tests for a variety of traits that resulted in successful detection of the most common autosomal aneuploidies through massive parallel sequencing of maternal plasma DNA. With the advancements in sequencing technologies also emerged the need for advancing the computational tools that took place by 2009. Accommodating the requisites of transcriptomics, metagenomics or discovering genetic variant, Bowtie, TopHat splice-aware aligner or BWA tools came into existence for aligning millions of short reads along with SAMtools and BreakDancer software for downstream analysis. 

The sequencing techniques have significantly contributed in revolutionising clinical care which is one of the most vital implementations of Whole Genome Sequencing. The recent COVID-19 outbreak was one such implementation where the sequencing technology proved to be a compelling event. The critical underlying factors were determined on the basis of this technology further helping in proposing effective treatment strategies for the massive outbreak. More such life transforming molecular genetic diagnosis is the dire necessity of the current global healthcare affairs, for the ever-evolving scenarios of disease outbreaks never fail to astonish humankind. However, there does exist the implementation of WGS in exploring successful treatment alternatives for the persistent fatal disorders like Cancer, but a lot more is yet to be prospected. The concept of genome sequencing still remains the most abstracted area amongst the researchers. With it also comes the future of therapeutic intervention with a dedicated approach on personalizing the treatment alternatives based on an individual’s inimitable genomic design. Such strategies are going to foster highly reliable and competent approaches in healthcare sectors thus leading to a promising future not just in medical but also in agricultural practices wherein plants and livestock can also benefit.

Authors Biography

Aakriti Sharma, an aspiring Biotechnologist from Delhi, India. She is a Postgraduate in Biotechnology

The post SEQUENCING GENOME – Revolutionising era in healthcare appeared first on InnoHEALTH magazine.

The most commonly explored Artificial intelligence (AI) has been a disruptive force in a number of industries in recent years, and the healthcare sector is one where it has the enormous potential to change. The potential of artificial intelligence (AI) to handle large volumes of data, identify patterns, and make highly accurate choices is opening up new avenues for various medical research projects and  personalized patient treatment. This new frontier in healthcare quality promises to increase overall operational efficiency, expedite administrative procedures, and improve personalized therapy in addition to improving diagnostic accuracy. AI technologies have the potential to completely change the way healthcare is delivered, improving patient outcomes and streamlining treatment for patients everywhere as they develop.

The AI market for healthcare has shown significant development; estimates place it at $6.6 billion by 2021, rising at a pace of 40%. Large datasets from wearable health monitors and medical records are becoming more widely available, and this rise is being propelled by developments in computer power and learning algorithms 10. AI has the ability to save treatment costs by up to 50% and improve patient outcomes by 30% to 40%, demonstrating the enormous economic impact technology will have on the healthcare sector. Additionally, the market for artificial intelligence in healthcare was estimated to be worth USD 16.3 billion in 2022 and is projected to increase at a compound annual growth rate (CAGR) of 40.2% to reach USD 173.55 billion by 2029.

AI in healthcare has the potential to completely change the  Healthcare industry by providing an unprecedented level of diagnostic accuracy, individualized treatment regimens, and effective  and efficient patient care management. AI may assist medical practitioners in making better decisions by utilizing large volumes of data, which will eventually improve patient outcomes and save expenses and time.Thus, the healthcare industry and AI are together transforming millions of lives globally.

EVOLUTION OF ARTIFICIAL INTELLIGENCE

Artificial Intelligence (AI) has emerged as a transformational technology that has remolded the landscape of numerous industries, ranging from finance and marketing to entertainment and so healthcare is no exception.When it comes to Healthcare, Artificial intelligence(AI) plays a pivotal role in transforming lives. It is concerned with building machines that can carry out operations that normally calls for human intellect.Artificial intelligence (AI) is not motivated by a survival instinct, in contrast to human intellect. However, our thoughts of artificial intelligence are usually associated with computers that want to outcompete humans and robots that resemble humans.We frequently employ artificial intelligence (AI) without realizing it. Artificial intelligence is pervasive, appearing in everything from Snapchat filters to Siri to Google Maps traffic reports.AI has paved the way to previously unattainable improvements in the overall standards of healthcare.AI has several uses in the healthcare sector which includes illness diagnosis, individualized treatment plans,Predictive Analytics,Drug Discovery and Development,Robotic Surgery and many more.

DIVERSIFIED APPLICATIONS OF AI IN HEALTHCARE 

Diagnostics and Imaging in Medicine

Medical imaging is now far more accurate and efficient because of AI. Deep learning algorithms have the ability to evaluate pictures from CT, MRI, and X-ray scans and diagnose anomalies and genetic defects with an accuracy level that is on par with or even higher than human radiologists. AI models like CheXNet and BoneView have been trained to recognize fractures, cancer, and other illnesses, allowing for quick diagnosis and treatment in healthcare facilities. In diagnostics and imaging Artificial Intelligence provides a great platform for precise diagnosis of a wide spectrum of diseases.

Predictive Analytics 

Anticipating disease outbreaks, patient admissions, and possible consequences is made easier with the use of AI-powered predictive analytics. Artificial intelligence (AI) can forecast a patient’s specific risks and suggest preventative actions by examining genetic information, lifestyle data, and electronic health records (EHRs). AI systems, for instance, can predict the risk of readmissions, enabling medical professionals to carry out focused treatments to lower hospital readmission rates and provide efficient care to the patient.

Personalized Medicines

Treatment regimens are customized for each patient by personalized medicine taking into account their genetic composition, way of life, and surroundings.

AI is essential to this because it analyzes vast amounts of genomic data to find genetic markers linked to certain diseases and how they respond to various therapies. This makes it possible to create individualized treatment plans that are less harmful and more successful.

Virtual Health Assistants

Virtual health assistants with AI capabilities are revolutionizing patient self-management and engagement. These digital assistants may book appointments, remind patients to take their meds, give medical information, and respond to questions related to  health. They improve overall health outcomes and increase patient adherence to treatment approaches.VHAs are intended to provide patients information, assistance, and direction regarding healthcare. These assistants help clients manage their health and wellbeing by interacting with them in a conversational way using artificial intelligence (AI) technology such as machine learning and natural language processing.

Robotic Surgery

Artificial intelligence (AI)-guided robotic-assisted surgeries provide more control, accuracy, and flexibility and a higher level of precision than conventional surgical techniques. AI algorithms help surgeons to minimize invasiveness and shorten recovery periods by helping them plan and carry out complicated surgeries like Prostatectomies, hysterectomies, cardiac valve repair, and complex gastrointestinal procedures. AI is used, for instance, by the da Vinci Surgical System to convert the larger, more fluid hand motions of a surgeon into tiny, more accurate movements of surgical tools within the body of the patient.

IS AI CHANGING LIVES IN HEALTHCARE?

According to recent studies AI tends to bring  a drastic change in the healthcare Industry changing numerous lives.Healthcare is changing dramatically as a result of artificial intelligence (AI), which holds the potential to improve patient outcomes, expedite processes, and customize medical care. The use of cutting-edge algorithms and machine learning models that can analyze enormous volumes of data, find patterns, and offer insights that were previously unachievable characterizes this new era of medical innovation. 

In the field of diagnosis and detection, artificial intelligence has made one of the biggest contributions to healthcare. Artificial intelligence (AI) systems, especially those built on deep learning, have shown to be very accurate in interpreting medical pictures, including CT, MRI, and X-ray scans. These algorithms are able to recognize minute irregularities that might be a sign of early-stage ailments such as neurological problems, cardiovascular issues, and malignancies. AI algorithms have made it possible to identify lung cancer nodules from CT images more accurately than human radiologists leading to early detection and efficient treatment interventions. AI is essential to personalized treatment in the field of genetics because of its capacity to evaluate massive information. 

AI can suggest individualized treatment strategies and anticipate a patient’s vulnerability to specific diseases by looking at their genetic information. Because the medicines are customized based on the genetic composition of the patient, this method not only maximizes the effectiveness of the drugs but also reduces side effects.Chatbots and virtual health assistants driven by AI are transforming patient care by offering round-the-clock assistance. By providing medication reminders, scheduling appointments, and responding to patient inquiries, these technologies help increase treatment plan adherence. By evaluating symptoms and suggesting the best course of action, virtual assistants may also triage patients, relieving the strain on medical staff and guaranteeing prompt treatment.

AI algorithms in the field of public health are able to forecast disease outbreaks by examining trends in a variety of data sources, such as traveler data, social media posts, and weather reports. These insights facilitate the implementation of preventative measures, efficient resource allocation, and the reduction of the burden of infectious illnesses by public health officials. AI has, for instance, been used to forecast influenza epidemics, enabling prompt vaccination drives and public education campaigns.

Healthcare administrative duties, such invoicing and medical paperwork, take a lot of time and are prone to mistakes. These jobs are being automated by AI, allowing medical staff to concentrate on patient care. Algorithms for natural language processing (NLP) may assure proper invoicing, code diagnoses and procedures, and transcribe medical notes—all while minimizing mistakes,human errors and administrative hassles.

Although AI has a lot of promises for the healthcare industry, there are a number of ethical and technological issues with it. Since AI systems handle sensitive patient data, data privacy and security must be guaranteed. Strong security measures need to be put in place to safeguard against hacks and illegal access to sensitive data and maintain confidentiality of patient’s information.

Another crucial issue with AI models is how to handle bias and fairness. In order to prevent biases that can result in unfair treatment, AI systems must be trained on a variety of datasets. In order to preserve confidence and responsibility in AI-driven healthcare, efforts must be made to guarantee the openness and explainability of AI choices.

NAVIGATING THE COMPLEXITIES: CHALLENGES OF AI IN HEALTHCARE

Artificial intelligence (AI) has become a formidable instrument that might completely transform the way healthcare is delivered. It has hitherto unseen possibilities for boosting operational effectiveness, optimizing resource allocation, and improving patient outcomes. But there are obstacles to overcome before AI can be successfully applied in healthcare. Healthcare companies confront several challenges in their quest to smoothly incorporate AI into their operations, ranging from technological difficulties to ethical dilemmas and legal barriers.

Data Accessibility and Quality

High-quality data is the cornerstone of every successful AI application in the healthcare industry. However, using AI is significantly hampered by the fragmented, siloed, and inconsistent quality of healthcare data. To properly train AI algorithms and provide insights that can be put to use, it is imperative to ensure that data is accessible and interoperable across heterogeneous systems. To overcome these obstacles and fully utilize AI, healthcare businesses need to invest in strong data governance frameworks, data standardization initiatives, and interoperability solutions.

Data privacy and compliance with regulations

One of the sectors with the highest levels of regulation is healthcare, which has strict guidelines for patient privacy and data security.Healthcare firms have a great deal of difficulty when implementing AI technologies while maintaining compliance with laws like the Health Insurance Portability and Accountability Act (HIPAA).Strict data privacy regulations must be followed by AI algorithms, and businesses need to put strong security measures in place to guard sensitive patient data from breaches or unwanted access.To develop and execute AI solutions that fulfill regulatory standards without compromising patient privacy or data security, healthcare providers, technology suppliers, and regulatory bodies must work closely together to navigate the complicated regulatory landscape.

Ethical and Societal Repercussions

AI in healthcare brings up important ethical and societal issues that need to be properly thought out and resolved. Healthcare companies must address a variety of ethical issues when implementing AI, from worries about algorithmic bias and fairness to issues with transparency, accountability, and algorithmic accountability. For healthcare organizations looking to maximize the advantages of AI while avoiding possible drawbacks, ensuring openness and accountability in AI-driven decision-making processes, eliminating biases in AI algorithms, and encouraging justice and fairness in healthcare delivery are crucial concerns.

Clinical Adoption and User Acceptance

The effective integration of AI technologies in clinical practice continues to be a substantial problem, despite the potential benefits of AI in healthcare. Healthcare professionals may be reluctant to use AI technology because they fear losing their jobs, losing their autonomy, or realizing that the precision and dependability of AI-driven suggestions would be compromised. To overcome these obstacles, extensive training and education initiatives, continuous involvement and support from clinical stakeholders, and thorough assessments of the clinical value, usability, and effects of AI solutions on patient outcomes are all necessary. Healthcare institutions may encourage a higher level of acceptance and use of AI technology in clinical practice by integrating clinicians in the design, development, and deployment of AI solutions.

Technological Integration and Complexity

Overcoming technical obstacles in algorithm creation, model training, and interaction with current clinical procedures and information systems are necessary for using AI in healthcare. Healthcare institutions have to successfully negotiate the challenges of incorporating artificial intelligence (AI) technologies into their current IT framework, guaranteeing smooth communication between medical equipment, electronic health records (EHRs), and other healthcare systems. Proficiency in data science, machine learning, and domain-specific healthcare knowledge are prerequisites for creating AI algorithms that are dependable, accurate, and therapeutically relevant. For AI technologies to be successfully implemented in healthcare, data scientists, physicians, and IT specialists must work together to overcome technological obstacles.

THE FUTURE CONTEMPLATION OF AI IN HEALTHCARE

The Advanced Genomics and Precision Medicine

It is anticipated that AI will be essential to the advancement of genomics and

exact medication. By doing an unparalleled analysis of genomic data,

scale, AI can provide fresh perspectives on the underlying genetics of illnesses

and pinpoint new therapeutic targets and regimens.This will leads to a possibility for the

development of individualized, highly customized therapies for various genetic disorders and helps in early detection and diagnosis.

AI and Internet of Things (IoT) Integration

Real-time patient monitoring and management will be improved by the integration of AI with IoT devices, such as wearable health monitors and smart medical equipment. IoT devices have the capacity to continually gather health data, which AI algorithms may then use to identify early warning indicators of numerous health problems and launch prompt action.A new era of technological innovation is being powered by the intersection of Artificial Intelligence (AI) and the Internet of Things (IoT), which is transforming industries and revolutionizing daily lives. With the use of AI, IoT devices can process and analyze enormous volumes of data and make deft judgments without the need for human interaction. New opportunities for productivity, automation, and connection are made possible by combining these two.

AI-Powered Therapeutic Discovery

AI’s capacity to forecast the interactions between various chemicals and biological targets holds the promise of completely changing the drug discovery process. This can save expenses and expedite the drug development process considerably.AI-powered models are also capable of identifying current medications that have potential for novel therapeutic uses.

Enhanced Patient Engagement

AI-powered solutions that offer individualized health information, reminders, and assistance will keep improving patient engagement.Chatbots and virtual health assistants will advance in sophistication to provide patients with a smooth and engaging medical experience.Artificial intelligence (AI) also improves  clinical decision support systems by giving real-time insights and suggestions based on patient data and the most recent medical research. This enhances patient outcomes by empowering clinicians to make better judgments.

Telemedicine and Remote care

The COVID-19 pandemic has expedited the assimilation of telemedicine, and artificial intelligence will augment the proficiencies of remote treatment. AI can help with virtual consultations, patient monitoring, and remote diagnostics, improving accessibility and convenience in healthcare.

Without a doubt, the future of healthcare quality lies in artificial intelligence. Healthcare delivery is changing as a result of its applications in robotic surgery, virtual health assistants, customized medication, predictive analytics, and medical imaging. AI in healthcare has enormous promise, but there are obstacles to be solved, including data protection, integrating with current systems, and ethical issues. AI technologies will open up new avenues for boosting efficiency, cutting costs, and improving patient care as they continue to develop. To improve patient outcomes and advance medical knowledge, healthcare must embrace artificial intelligence (AI).With its breakthrough potential to improve patient outcomes, increase operational efficiency, and advance medical research, artificial intelligence (AI) offers a new frontier in the excellence of healthcare. By utilizing AI, we are not only redefining what is feasible in the medical field but also laying the foundation for a day when proactive, personalized, and precise treatment will be the hallmarks of medical excellence. Realizing the full promise of AI in healthcare will need ongoing innovation, teamwork, and ethical stewardship as we traverse this fascinating frontier.

Authors Biography

Mercilina Norman is currently pursuing an MBA in healthcare and hospital administration. She also has experience as a staff nurse.

The post Artificial intelligence: The new frontier in healthcare excellence appeared first on InnoHEALTH magazine.

1. E-pharmacy has seen significant growth in recent years. Can you share your insights on how digital health platforms are revolutionizing the way medicines are accessed and delivered to consumers?
   E-pharmacies have significantly enhanced accessibility, affordability, convenience & comfort while empowering customers with useful information to manage their healthcare better. We let customers request medicines by uploading a prescription through a convenient app/ website and have them delivered to their homes. This service is especially helpful for people who live in rural places, elderly people who have mobility problems, or need to get prescription refills on a regular basis. Also, many times medicines are not easily available in one geography, while they may be available in other locations – a digital platform manages to ensure better availability of medicines as needed by consumers. Laboratory tests and Teleconsultations are also integrated into digital health systems, further empowering patients’ access to medical consultations. These developments ensure better prescription adherence and speed up obtaining medications. Digital health platforms enhance full transparency and safety in medication delivery, given everything is end to end tracked and traced. Also, they offer detailed information on drug availability, pricing, and alternatives, allowing consumers to make informed choices. Additionally, the well organized platforms incorporate stringent verification processes and quality checks to ensure that medications are genuine and safe. By analyzing patient data, these platforms can provide dosage reminders, health tips and even managed care programs, improving overall health outcomes.
   
   
2. How do digital health platforms leverage their platform to empower users in making informed decisions about their health, accessing healthcare services, and adopting preventive healthcare measures?
   Platforms for digital health give consumers access to a multitude of information from around the world, and use that for empowering our customers with deeper knowledge. These services provide detailed information of the medicines patients are taking and many other health related information such as – symptom checks, instructional materials, and guidance from medical specialists. They let users schedule appointments, manage their health data, and get reminders for things like medicine and checkups. Users may monitor vital signs and activity levels by incorporating wearable technology, which promotes proactive health management. Educational content, including articles, videos, and webinars on various health topics, keeps users informed and engaged. Additionally, community forums and support groups allow users to share experiences, seek advice, and gain support from peers facing similar health challenges promoting preventive health.
   
   
3. Antimicrobial resistance (AMR) is a growing concern globally. How do you see digital health platforms playing a role in addressing AMR, particularly in ensuring responsible antibiotic use and promoting awareness among consumers?
   Digital health platforms play a crucial role in combating AMR. Given that every dispensation is tracked digitally end to end, it is much easier to ensure proper Antibiotic adherence through digital platforms. Ideally, all Antibiotic dispensation should be on similar platforms only, to ensure there is no self medication and prescription abuse for antibiotics. Also, the platforms play a role towards promoting responsible antibiotic use and increasing awareness in both the patients and doctors associated with their platforms. Educational content about the dangers of AMR and the importance of completing antibiotic courses is readily available to consumers. Moreover, these platforms can be leveraged to track antibiotic prescriptions and usage patterns, providing data that can be analyzed to identify and mitigate misuse trends. Digital health platforms can integrate decision support tools for healthcare professionals to aid in antibiotic prescribing. This data-driven approach aids in developing targeted interventions to curb AMR. Platforms should use their reach and influence to advocate for policy changes and investments in AMR prevention and control.
   
   
4. Artificial intelligence (AI) is increasingly being integrated into e-pharmacy platforms to enhance services and improve efficiency. Can you discuss some of the AI-driven innovations implemented to enhance user experience and optimize healthcare outcomes?
   AI enhances e-pharmacy services by improving accuracy, efficiency, and user experience. AI algorithms personalize medication recommendations based on individual health profiles and past behaviors. Chatbots powered by AI provide instant customer service, answering queries and guiding users through the purchasing and delivery process. AI-driven predictive analytics help manage inventory by forecasting demand, reducing the likelihood of stockouts or overstocking. Furthermore, AI applications in drug interaction checks ensure safe medication combinations, enhancing patient safety. We are also working upon data science models which can digitize typewritten and handwritten health records, which again can serve the ecosystem beyond just pharmacies.
   
   
5. The online sale of medicines has been subject to regulatory scrutiny in many countries, including India. What are your thoughts on potential new regulations governing the online sale of medicines, and how do you foresee these regulations impacting the e-pharma industry?
   A lot of controversy around online pharmacies in many countries pertains to cross border trade of medicines, for which many countries have regulated that online pharmacies have to be domiciled within the country only. Also, today China, Europe, Latin America, USA – all have ePharmacies thriving. Especially post covid, the need for a national digital infrastructure to access medication is well recognized. In India, presently, all dispensation is governed by the Drugs & Cosmetics Act & Rules 1945, and players fully comply with those provisions. In addition, the players need to comply with IT Act and other rules governing retail and eCommerce. However, we do feel the time has come for the country to have an integrated and updated set of rules, given that today the models are governed under multiple Acts and harmonizing them will ensure much better ease of doing business. Also, the various upcoming innovative models at play may have specific requirements. The impending new Drugs and Medical Devices Act has already mentioned online sales of medicines would be specifically addressed. We will continue our engagements with the regulators to help frame comprehensive sectoral guidelines that ensure the safe and efficient operation of e-pharmacies.
   
   
6. What steps do online platforms typically implement to prevent the sale of counterfeit medications?
   ePharmacies are fundamentally well positioned to ensure accountability in the supply chain, since all medicines are end-to-end trackable and traceable here from supplier to patient, unlike in the open market where a lot of such medicines are dispensed without a clear traceability, often involving cash transactions. Digitization of the supply chain is the largest weapon in the fight against counterfeit, and the ePharmacy model naturally has that advantage. Also, given all transactions come with an invoice, there is proper accountability of various players embedded in the system, besides better tax realization for the government. Additionally, ePharmacies implement several measures to prevent the sale of counterfeit medications. All good ePharmacies have a robust partner onboarding mechanism in place. They source products directly from reputed manufacturers and authorized distributors, which is critical towards ensuring the authenticity of stock. Advanced tracking systems and barcoding technology enable traceability from the distributor to the consumer. ePharmacies also perform regular audits and quality checks, and take consumer feedback seriously for end to end checks.
   
   
7. What are some of the key challenges facing the e-pharma industry, and how are digital health platforms addressing these challenges to ensure compliance, safety, and quality in the delivery of healthcare services?
   The key challenge for the ePharmacy industry today is around ease of doing business. All players have to comply with various laws and rules which come under various acts, and many times a single department is not aware of the other laws governing the ecosystem. For example, it is commonly seen that a local Drug Inspector is not aware of the IT Act, Consumer Protection Act or eCommerce rules, and it is a cumbersome process to respond to various issues that may come up. Also, there is a need for a level playing field, and it is well known that prescription requirements, presence of pharmacists and other regulations are often not equally imposed. As a result, a lot of customers on ePharmacy platforms are disappointed that we seek prescriptions when they easily get the same medicines without in the open market. Another challenge is around ensuring data security, and with the upcoming data privacy laws, there is a need to set up adequate systems to manage that. Digital health platforms address these challenges by investing in secure, scalable IT infrastructure and adopting comprehensive compliance protocols. They collaborate with regulatory bodies to stay updated on regulations and adapt practices accordingly. To ensure product authenticity, e-pharmacies partner with companies and their authentic vendors, leverage advanced technologies like blockchain and AI for supply chain management and verification. Continuous stakeholder engagement and user education and transparent operations build consumer trust and ensure quality service delivery. Digital health platforms prioritize data privacy and security by implementing robust encryption protocols, access controls, and data anonymization techniques to protect patient information.
   
   
8. With the rapid advancement of technology, what do you envision as the next digital revolution in the healthcare industry, and how do you see digital health platforms adapting to and driving this transformation?
   The next digital revolution in healthcare will involve the integration of advanced AI, machine learning, and the Internet of Medical Things (IoMT). These technologies will enable more precise and faster diagnostics, personalized treatment plans taking into account health data and real time wearable data, and seamless interoperability among different healthcare systems. Digital health platforms will likely evolve to offer holistic health management ecosystems, integrating fitness, nutrition, mental health, and medical care into a single user interface. This transformation will enhance preventive care, early detection of diseases, and patient engagement. 
   
   
9. Personalized medicine and telemedicine are emerging trends in healthcare. How do you see digital health platforms evolving to incorporate these trends into their service offerings, and what opportunities do they present for improving patient care?
   Personalized medicine and telemedicine may be driven faster by and also effectively integrated into digital health platforms, providing customized healthcare solutions that consider genetic, environmental, and lifestyle aspects. Genetic data will be used by platforms to offer individualized medication recommendations and health guidance. The field of telemedicine is expected to grow, offering a wide range of virtual care solutions such as digital treatments, remote monitoring, and expert consultations. Opportunities to enhance patient outcomes, lower healthcare costs, and broaden access to high-quality treatment are presented by these trends. Resultant Chronic disease management programs, virtual care solutions, remote patient monitoring and home healthcare will lead to better health outcomes. 
   
   
10. Data privacy and security are critical considerations in the digital health space. How do digital health platforms ensure the confidentiality and integrity of user data while leveraging data analytics to enhance their services?
    To ensure data privacy and security, digital health platforms implement robust cybersecurity measures, including encryption, secure data storage, and multi-factor authentication. They adhere to regulations like national data protection laws to safeguard user data. Regular security audits, employee training on data privacy, and transparent data handling practices enhance trust. 
    
    
11. Collaboration and partnerships are essential for the success of digital health platforms. Can you share some examples of successful collaborations undertaken to expand reach and enhance service offerings?
    Partnerships with academic institutions, technology businesses, pharmaceutical companies, and healthcare providers are some of the key digital health collaborations. Partnerships with pharmaceutical firms, for instance, can increase medicine availability and optimize supply chains and improve access to patient support programs. By using cutting-edge technologies like artificial intelligence, partnerships with tech companies can improve platform capabilities. Innovation in digital health solutions is being fostered through cooperative research collaborations with academic institutions. These alliances broaden their clientele, improve the services they provide, and propel the sector forward.
    
    
12. Finally, what is your vision for the future of e-pharmacy and digital health, and how do you see these platforms contributing to the advancement of healthcare delivery and accessibility?
    India today has an opportunity to create the new model of digital access to healthcare, which is not only a model for India but for the entire global south. Digital Health platforms hold the promise of making healthcare personalized, integrated, accessible and affordable – and in all these dimensions India is well endowed to lead the world in creating the new age model and technology. E-pharmacy and digital health will prosper in the future when state-of-the-art technology is combined with a patient-first mentality. E-pharmacies are now transforming into all-inclusive health management platforms that provide a variety of services, including telemedicine, diagnostics services, personalized health advice, and pharmaceutical delivery. E-pharmacy and digital health platforms have the potential to transform by delivering personalized and precision healthcare, empowering patients, promoting collaborative care models, expanding access and equity, and driving continuous innovation and collaboration across the healthcare ecosystem. By leveraging technology, data-driven insights, and collaborative partnerships, these platforms can contribute to a future where healthcare is accessible, equitable, and patient-centered, ultimately improving the health and well-being of individuals and communities. By increasing efficiency, personalization, and accessibility, digital health platforms will play an integral part in improving healthcare delivery.

The post Revolutionizing Healthcare: Insights into the Future of E-Pharmacies and Digital Health Platforms appeared first on InnoHEALTH magazine.

With the increasing importance and awareness of healthcare, the quality of care and patient safety have gained global concern. In this context, the need for biomarkers cannot be denied at all. 

What are biomarkers?

The term “biomarker” is a merged/blended word of “biological marker”. Biomarkers indicate the underlying biological processes/events, either normal or abnormal taking place in one’s body. Biological markers might be either present or absent; or might be increased or decreased; or might be present in a changed form. They serve as indicators of an underlying disease process, determining the risk factors associated with a disease process. They provide crucial clues about one’s current health or to future health status. 

Biomarkers can be found in blood, urine, stool, tumor tissue or body fluids. They are produced by the normal cells in response to a disease process or cancer or by the cancer cells itself. Biomarkers are available for various diseases: heart diseases, neurological diseases, renal diseases, infective disorders, genetic disorders, cancers etc.

What are the characteristics of an ideal biomarker?

An ideal biomarker should have the following characteristics:

• It should be sensitive.
• It should correlate with the severity of disease/damage.
• It should express itself early in the disease progression.
• It should be measurable in blood/urine.
• It should be stable in a tissue so that it can be measured even after sometime has passed.
• It should be visible prior to the histopathological changes.
• It should give reproducible results.
• It should be portable, reliable, and immediate.
• It should be precise, sensitive and specific.

What are the types of biomarkers?

A. Molecular, histologic, radiographic or physiologic biomarkers.
B. Molecular biomarkers can be:

• DNA (genes)
• Proteins
• Hormones

C. The other type of classification is:

1. Diagnostic biomarkers: Detects/ confirms the presence /absence of a disease condition. Also helps in identifying the disease subtype and helps in differentiating between different diseases. Example: High sensitivity Troponin assay helps in diagnosing myocardial necrosis.
2. Predictive/ prognostic biomarker: Helps to indicate how a disease may develop in an individual when a disorder is already diagnosed. Also helps to determine which patients might be benefitted from a specific treatment plan. To identify  the likelihood of a clinical event, disease recurrence, or disease progression in patients with a disease.
3. Monitoring biomarker: This type of biomarker can be measured serially in order to assess the status of a disease. Example: Measurement of HbA1C, LDL cholesterol levels, INR (to adjust the dose of anticoagulants) etc.
4. Susceptibility biomarker: It indicates the risk for developing a disease in an individual who is currently not having any disease.
5. Safety biomarker: It is measured before/ after an exposure to a medical intervention to indicate the likelihood, presence or extent of toxicity as an adverse event.
6. Treatment- response biomarker: Helpful to differentiate patients on the basis of their outcomes related to efficacy and side effects (responders/non-responders and patients with/without adverse drug reactions).

Macromolecules such as nucleic acids, genetic alterations, and protein molecules as well as intact cells are utilized as diagnostic biomarkers in breast cancer.

Emerging biomarkers in various fields of Pathology:

1. Myeloid neoplasms biomarkers: 

• Immunohistochemistry (IHC) plays an indispensable role in analyzing biomarkers that play an important role in treatment of patients with myeloid neoplasms.
• Cluster of differentiation markers or CD markers are the most commonly used leukemia biomarkers. CD marker specific antibodies are used for cell sorting, identification and leukemia diagnosis.
• Genetic abnormalities have been correlated with Chronic myeloid leukemia (CML) in the blast phase. The genes involved are as follows: 

1. In regulation of cell apoptosis and proliferation: Epidermal growth factor receptor (EGFR), tumor protein p53 (TP53)
2. In cell adhesion: Catenin beta 1 (CTNNB1),
3. Genes associated with TGF Beta: Transforming growth factor beta 1 and 2 (TGFB1, TGFB2)
4. TNF-alpha pathways: Tumor necrosis factor-alpha (TNFA), Nuclear factor kappa B subunit 1 (NFKB1)
5. MicroRNAs are also involved in CML: miRNA -451 nad miRNA -21

2. Breast cancer biomarkers:

As we all are aware, the three most important markers for breast cancer are:

• Estrogen receptor (ER)
• Progesterone receptor (PR)
• HER 2 neu
• Ki-67
• P53

Some of the single blood-based biomarkers in detecting breast cancer are: Human epidermal growth factor receptor 2 (HER2), Cancer Antigen 15-3 (CA 15-3), Carcinoembryonic Antigen (CEA), MUC1.

Macromolecules such as nucleic acids, genetic alterations, and protein molecules as well as intact cells are utilized as diagnostic biomarkers in breast cancer. Recently it is found that aberrant DNA methylation is linked to breast cancer. MAST1, PRDM14, ZNF177 irregular DNA methylation variants were found and verified as prospective breast cancer molecular indicators. Circulating proteins are used as screening biomarkers such as Trefoil factor TFF1, 2, 3. Micro RNA such as miR-145, 221 and 21 are found in the blood of breast cancer individuals.

3. Colorectal cancers (CRC) biomarkers:

• Tumor based biomarkers: Microsatellite instability (MSI) analysis, BRAF and KRAF mutation analysis. Micro RNAs also contribute to oncogenesis in CRC.
• Stool  biomarkers:  Fecal blood tests (gFOBT) is based on the detection of pseudoperoxidase activity of heme in stool samples due to bleeding in adenomatous / neoplastic lesions. Stool immunohistochemical test (FIT) and detection of Vimentin methylation.
• DNA based tests: Mutations in key genes TP53 and APC
• RNA based tests: Detection of tumor mRNA transcripts such as PTGS2 and MMP7.
• Blood based biomarkers: CEA

4. Endometrial cancer biomarker: K-RAS, HER2/neu, EGFR, PI3KCA, FGFR2, PTEN, p53.
5. Neurodegenerative disease biomarkers: Amyloid beta, Total tau protein, Phosphorylated Tau Protein.
6. Biomarkers in diabetes: HbA1C, fasting plasma glucose (FGP), Oral glucose tolerance test (OGTT). Adiponectin, C-reactive protein (CRP), ferritin and interleukin-2 receptor A.

The use of biomarkers is not only limited to cancer but has a widespread use in all the major fields of medicine and research. “The biomarkers are undoubtedly a boon to clinical practice.”

“Composed by: Dr. Shubha.H.V is a Consultant Pathologist/Lab Head, SRL Diagnostics, Fortis Hospital, Rajajinagar, Bangalore. “

The post Evolving Biomarkers in Pathology: Unveiling new avenues for disease detection and prognosis appeared first on InnoHEALTH magazine.